Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Papers: 14 Nov 2014 - 21 Nov 2014
Papers: 24 Jun 2013 - 1 Jul 2013
Papers: 13 Sep 2013 - 20 Sep 2013
Papers: 13 Dec 2015 - 20 Dec 2015
Total Brain Sodium on MRI Linked to More Severe MS
Papers: 10 Jul 2015 - 17 Jul 2015
Papers: 5 Jun 2015 - 12 Jun 2015
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.
Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
MS Research Roundup: October 3, 2014
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
MRI monitoring of spinal cord changes in patients with multiple sclerosis.
Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy.
Papers: 26 Jul 2013 - 2 Aug 2013
Is progressive multiple sclerosis a gray matter disease?
MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability.
Papers: 19 Jun 2015 - 26 Jun 2015
Disability as an outcome in MS clinical trials.
Papers: 12 Jun 2015 - 19 Jun 2015
Papers: 28 Aug 2015 - 4 Sep 2015
Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
Papers: 16 Oct 2015 - 23 Oct 2015
Papers: 10 Apr 2015 - 17 Apr 2015
Estrogens, Neuroinflammation and Neurodegeneration.
Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Pages
« first
‹ previous
…
25
26
27
28
29
30
31
32
33
…
next ›
last »
